Glycosidase inhibitors: Update and perspectives on practical use

Glycobiology

Volumn 13, Issue 10, 2003, Pages

  Asano, Naoki ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Agrochemicals; Antidiabetic agents; Antiviral agents; Genetic disorders; Glycosidase inhibitors

Indexed keywords

4 ACETAMIDO 3 GUANIDINOBENZOIC ACID; 4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; ACARBOSE; AGALSIDASE BETA; AGRICULTURAL CHEMICAL; ALGLUCERASE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; ANTIVIRUS AGENT; CARBOHYDRATE; CASTANOSPERMINE; CASTANOSPERMINE 6 BUTYRATE; CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR; FAGOMINE; GLYCOPROTEIN; GLYCOSIDASE; GLYCOSIDASE INHIBITOR; IMIGLUCERASE; MDL 25647; MIGLITOL; NOJIRIMYCIN; OLIGOSACCHARIDE; OSELTAMIVIR; PERAMIVIR; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALIDAMYCIN DERIVATIVE; VALIOLAMINE; VOGLIBOSE; ZANAMIVIR; ZIDOVUDINE;

AGRICULTURE; BACTERIUM CULTURE; CANCER; CARBOHYDRATE SYNTHESIS; CATALYSIS; CLINICAL TRIAL; DIABETES MELLITUS; DIARRHEA; DRUG ACTIVITY; DRUG DESIGN; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG STRUCTURE; DRUG USE; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; GENETIC DISORDER; HUMAN; HYDROLYSIS; LYSOSOME STORAGE DISEASE; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN TRANSPORT; QUALITY CONTROL; REVIEW; STREPTOMYCES; TREATMENT PLANNING; VIRUS CELL INTERACTION; VIRUS INFECTION;

ANTIVIRAL AGENTS; ENZYME INHIBITORS; GLYCOSIDE HYDROLASES; HYPOGLYCEMIC AGENTS; LYSOSOMAL STORAGE DISEASES;

BACTERIA (MICROORGANISMS); STREPTOMYCES;

EID: 0242287992     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/cwg090     Document Type: Review

References (133)

1. Abe, A. and Shayman, J.A. (1998) Purification and characterization of 1-O-acylceramide synthetase, a novel phospholipase A2 with transacylase activity. J. Biol. Chem., 273, 8467-8474.
2. Abe, A., Inokuchi, J., Jimbo, M., Shimeno, H., Nagamatsu, A., Shyman, J.A., Shukla, G.S., and Radin, N.S. (1992) Improved inhibitors of glucosylceramide synthase. J. Biochem. (Tokyo), 111, 191-196.
3. Abe, A., Radin, N.S., Shayman, J.A., Wotring, L.L., Zipkin, R.E., Sivakumar, R., Ruggieri, J.M., Carson, K.G., and Ganem, B. (1995) Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth. J. Lipid Res., 36, 611-621.
4. Abe, A., Radin, N.S., and Shayman, J.A. (1996) Induction of glucosylceramide synthase by synthase inhibitors and ceramide. Biochim. Biophys. Acta, 1299, 333-341.
5. Andersen, B., Rassov, A., Westergaard, N., and Lundgren, K. (1999) Inhibition of glycogenolysis in primary rat hepatocytes by 1,4-dideoxy-1,4-imino-D-arabinitol. Biochem. J., 342, 545-550.
6. Ando, O., Satake, H., Itoi, K., Sato, A., Nakajima, M., Takahashi, S., Haruyama, H., Ohkuma, Y., Kinoshita, T., and Enokita, R. (1991) Trehazolin, a new trehalase inhibitor. J. Antibiot., 44, 1165-1168.
7. Ando, O., Kifune, M., and Nakajima, M. (1995) Effects of trehazolin, a potent trehalase inhibitor, on Bombyx mori and plant pathogenic fungi. Biosci. Biotech. Biochem., 59, 711-712.
8. Anzeveno, P.B., Creemer, L.J., Daniel, J.K., King, C.-H.R., and Liu, P.S. (1989) A facile, practical synthesis of 2,6-dideoxy-2,6-imino-7-O-β-D-glucopyranosyl-D-glycero-L-gulo-heptitol (MDL 25,637). J. Org. Chem., 54, 2539-2542.
9. Aoki, F.Y. (1998) Amantadine and rimantadine. In Nicholson, K.G., Webster, R.G., and Hay, A.J. (Eds.), Textbook of influenza. Blackwell Science, Oxford, pp. 457-476.
10. Arai, N., Shiomi, K., Yamaguchi, Y., Masuma, R., Iwai, Y., Tuberg, A., Kölbl, H., and Omura, S. (2000) Argadin, a new chitinase inhibitor, produced by Clonostachys sp. FO-7314. Chem. Pharm. Bull., 48, 1442-1446.
11. Asano, N., Yamaguchi, T., Kameda, Y., and Matsui, K. (1987) Effect of validamycins on glycohydrolases of Rhizoctonia solani. J. Antibiot., 40, 526-532.
12. Asano, N., Takeuchi, M., Kameda, Y., Matsui, K., and Kono, Y. (1990) Trehalase inhibitors, validoxylamine A and related compounds as insecticides. J. Antibiot., 43, 722-726.
13. Asano, N., Tanaka, K., Kameda, Y., and Matsui, K, (1991) All eight possible mono-β-D-glucosides of validoxylamine A. II. Biological activities. J. Antibiot., 44, 1417-1421.
14. Asano, N., Kato, A., and Matsui, K. (1996) Two subsites on the active center of pig kidney trehalase. Eur. J. Biochem., 240, 692-698.
15. Asano, N., Nishida, M., Kizu, H., Matsui, K., Watson, A.A., and Nash, R.J. (1997) Homonojirimycin isomers and glycosides from Aglaonema treubii. J. Nat. Prod., 60, 98-101.
16. Asano, N., Ishii, S., Kizu, H., Ikeda, K., Yasuda, K., Kato, A., Martin, O.R., and Fan, J.-Q. (2000) In vitro inhibition and intracellular enhancement of lysosomal α-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonijirimycin and its derivatives. Eur. J. Biochem., 267, 4179-4186.
17. Barton, N.W., Furbish, F.S., Murray, G.J., Garfield, M., and Brady, R.O. (1990) Therapeutic response to intravenous infusions of glucocerebrosidase in patient with Gaucher disease. Proc. Natl Acad. Sci. USA, 87, 1913-1916.
18. 1-antitrypsin isolated from human liver. FEBS Lett., 177, 179-183.
19. Blattner, R., Gerard, P., and Spindler-Barth, M. (1997) Synthesis and biological activity of allosamidin and allosamidin derivatives. Pestic. Sci., 50, 312-318.
20. Block, T.M., Lu, X., Platt, F.M., Foster, G.R., Gerlich, W.H., Blumberg, B.S., and Dwek, R.A. (1994) Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc. Natl Acad. Sci. USA, 91, 2235-2239.
21. Block, T.M., Lu, X., Mehta, A.S., Blumberg, B.S., Tennant, B., Ebling, M., Korba, B., Lansky, D.M., Jacob, G.S., and Dwek, R.A. (1998) Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nat. Med., 4, 610-614.
22. Bortone, K., Monzingo, A.F., Ernst, S., and Robertus, J.D. (2002) The structure of an allosamidin complex with the Coccidiodes immitis defines a role for second acid residue in substrate-assited mechanism. J. Mol. Biol., 320, 293-302.
23. Brady, R.O., Gal, A.E., Bradley, R.M., Martensson, E., Warshaw, A.L., and Laster, L. (1967) Enzymatic defect in Fabry's disease. Ceramide-trihexosidase deficiency. N. Eng. J. Med., 276, 1163-1167.
24. Bychkova, V.E. and Ptitsyn, O.B. (1995) Folding intermediates are involved in genetic diseases? FEBS Lett., 359, 6-8.
25. Chand, P., Babu, Y.S., Bantia, S., Chu, N., Cole, B., Kotian, P.L., Laver, W.G., Montgomery, J.A., Pathak, V.P., Petty, S.L., and others. (1997) Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design. J. Med. Chem., 40, 4030-4052.
26. Chand, P., Kotian, P.L., Dehghani, A., El-Kattan, Y., Lin, T.-H., Hutchison, T.L., Babu, Y.S., Bantia, S., Elliott, A.J., and Montgomery, J.A. (2001) Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity. J. Med. Chem., 44, 4379-4392.
27. Cheng, S.H., Gregory, R.J., Marshall, J., Paul, S., Souza, D.W., White, G.A., O'Riordan, C.R., and Smith, A.E. (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell, 63, 827-834.
28. Cohen, E. and Cashida, J.E. (1982) Properties and inhibition of insect integumental chitin synthetase. Pestic. Biochem. Physiol., 17, 301-306.
29. Colman, P.M., Varghese, J.N., and Laver, W.G. (1983) Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature, 303, 41-44.
30. Cook, C.S., Karabatsos, P.J., Schoenhard, G.L., and Karim, A. (1995) Species dependent esterase activities for hydrolysis of an anti-HIV prodrug glycovir and bioavailability of active SC-48334. Pharm. Res., 12, 1158-4164.
31. Cox, T., Lachmann, R., Hollak, C., Aerts, J., van Weely, S., Hrebicek, M., Platt, F., Butters, T., Dwek, R., Moyses, C., and others. (2000) Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet, 355, 1481-1485.
32. Defaye, J., Driquez, H., and Herssat, B. (1980) Some recent aspects of the specificity and mechanism of action of trehalose. In Marshall, J.J. (Ed.), Mechanism of Saccharide Polymerization and Depolymerization. Academic Press, New York, pp. 331-353.
33. Defronzo, R.A., Bonadonna, R.C., and Ferrannini, E. (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care, 15, 318-368.
34. Denning, G.M., Anderson, M.P., Amara, J.F., Marshall, J., Smith, A.E., and Welsh, M.J. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature, 358, 761-764.
35. Desnick, R.J., Ioannou, Y.A., and Eng, C.M. (1995) α-Galactosidase A deficiency: Fabry disease. In Scriver, C.R., Beaudet, Sly, W.S., and Valle, D. (Eds.), The metabolic and molecular bases of inherited disease, vol. 2. McGraw-Hill, New York, pp. 2741-2784.
36. Drutz, D.J. and Catanzaro, A. (1978) Coccidiodomycosis. Am. Rev. Resp., 17, 559-585.
37. Elbein, A.D. (1974) The metabolism of α,α-trehalose. Adv. Carbohydr. Chem. Biochem., 30, 227-256.
38. Elbein, A.D. (1987) Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Ann. Rev. Biochem., 56, 497-534.
39. Elbein, A.D. (1991) Glycosidase inhibitors: inhibitors of N-linked oligosaccharide processing. FASEB J., 5, 3055-3063.
40. Elbein, A.D., Pan, Y.T., Pastuszak, I., and Carroll, D. (2003) New insights on tehalose: a multifunctional molecule. Glycobiology, 13, 17R-27R.
41. Ezure, Y., Murao, S., Miyazaki, K., and Kawamata, M. (1985) Molanoline (1-deoxynojirimycin) fermentation and its improvement. Agric. Biol. Chem., 49, 1119-1125.
42. Fan, J.-Q., Ishii, S., Asano, N., and Suzuki, Y. (1999) Accelerated transport and maturation of lysosomal α-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat. Med., 5, 112-115.
43. Ficher, P.B., Collin, M., Karlsson, G.B., Lames, W., Butters, T.D., Davis, S.J., Gordon, S., Dwek, R.A., and Platt, F.M. (1995) The α-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding. J. Virol., 69, 5791-5797.
44. Fosgerau, K., Westergaard, N., Quistorff, B., Grunner, N., Kristiansen, M., and Lundgren, K. (2000) Kinetic and functional characterization of 1,4-dideoxy-1,4-imino-D-arabinitol: a potent inhibitor of glycogen phosphorylase with antihyperglyceamic effect in ob/ob mice. Arch. Biochem. Biophys., 380, 274-284.
45. Fu, Y.-K., Hart, T.K., Jonak, Z.L., and Bugelski, P.J. (1993) Physico-chemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120. J. Virol., 67, 3818-3825.
46. Gething, M.-J. and Sambrook, J. (1992) Protein folding in the cells. Nature, 355, 33-45.
47. Gooday, G.W. (1989) Chitin metabolism as a target for antifungal and antiparasitic drugs and agrochemicals. Prog. Ind. Microbiol., 27, 139-150.
48. Hayden, F.G. and Couch, R.B. (1992) Clinical and epidemiological importance of influenza A viruses resisitant to amantadine and rimantadine. Rev. Med. Virol., 2, 89-96.
49. Helenius, A., Marquardt, T., and Braakmann, I. (1992) The endoplasmic reticulum as a protein folding compartment. Trends Cell Biol., 2, 227-231.
50. Holzer, C.T., von Itzstein, M., Jin, B., Pegg, M.S., Stewart, W.P., and Wu, W.Y. (1993) Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-dihydro-N-acetyl-neuraminic acid modified at the C-4 position. Glycoconj. J., 10, 40-44.
51. Horii, S., Kameda, Y., and Kawahara, K. (1972) Studies on validamycins, new antibiotics. VIII. Isolation and characterization of validamycins, C, D, E and F. J. Antibiot., 25, 48-53.
52. Horii, S., Fukase, H., Matsuo, T., Kameda, Y., Asano, N., and Matsui, K. (1986) Synthesis and α-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents. J. Med. Chem., 29, 1038-1046.
53. Houston, D.R., Shiomi, K., Arai, N., Omura, S., Peter, M.G., Turberg, A., Synstad, B., Eijsink, V.G.H., and van Aalten, D.M.F. (2002) High-resolution structures of a chitinase complexed with natural product cyclopentapeptide inhibitors: mimicry of carbohydrate substrate. Proc. Natl Acad. Sci. USA, 99, 9127-9132.
54. Hurtley, S.M. and Helenius, A. (1989) A protein oligomerization in the endoplasmic reticulum. Annu. Rev. Cell Biol., 5, 277-307.
55. Ikeda, K., Takahashi, M., Nishida, M, Miyauchi, M., Kizu, H., Kameda, Y., Arisawa, M., Watson, A.A., Nash, R.J., Fleet, G.W.J., and Asano, N. (2000) Homonojirimycin analogues and their glucosides from Lobelia sessilifolia and Adenophora sp. (Campanulaceae). Carbohydr. Res., 323, 73-80.
56. Inoue, S., Tsuruoka, T., and Niida, T. (1966) The structure of nojirimycin, a piperidinose sugar antibiotic. J. Antibiot., 19, 288-292.
57. Inoue, S., Tsuruoka, T., Ito, T., and Niida, T. (1967) Structure and synthesis of nojirimycin. Tetrahedron, 23, 2125-2144.
58. Ishii, S., Kase, R., Sakuraba, H., and Suzuki, Y. (1993) Characterization of a mutant α-galactosidase gene product for the late-onset cardiac form of Fabry disease. Biochem. Biophys. Res. Commun., 197, 1585-1589.
59. Ishii, S., Kase, R., Okumiya, T., Sakuraba, H., and Suzuki, Y. (1996) Aggregation of the inactive form of human α-galactosidase in the endoplasmic reticulum. Biochem. Biophys. Res. Commun., 220, 812-815.
60. Iwasa, T., Yamamoto, H., and Shibata, M. (1970) Studies on validamycins, new antibiotics. I. Streptomyces hygroscopicus var. limoneus nov. var., validamycin-producing organism. J. Antibiot., 23, 595-602.
61. Iwasa, T., Higashide, H., Yamamoto, H., and Shibata, M. (1971) Studies on validamycins, new antibiotics. II. Production and biological properties of validamycins A and B. J. Antibiot., 24, 107-113.
62. Jakobsen, P., Lundbeck, J.M., Kristiansen, M., Breinholt, J., Demuth, H., Pawlas, J., Torres Candela, M.P., Andersen, B., Westergaard, N., Lundgren, K., and Asano, N. (2001) Iminosugars: potential inhibitors of liver glycogen phosphorylase. Bioorg. Med. Chem., 9, 733-744.
63. Joubert, P.H., Foukaridis, G.N., and Bopape, M.L. (1987) Miglitol may have a blood glucose lowering effect unrelated to inhibition of α-glucosidase. Eur. J. Clin. Pharmacol., 31, 723-724.
64. Joubert, P.H., Venter, H.L., and Foukaridis, G.N. (1990) The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism? Br. J. Clin. Pharmacol., 30, 391-396.
65. Junge, B., Matzke, M., and Stltefuss, J. (1996) Chemistry and structure-activity relationships of glucosidase inhibitors. In Kuhlmann, J. and Puls, W. (Eds.), Handbook of experimental pharmacology, vol. 119. Springer-Verlag, New York, pp. 411-482.
66. Kameda, Y., Asano, N., Yoshikawa, M., Takeuchi, M., Yamaguchi, T., Matsui, K., Horii, S., and Fukase, H. (1984) Valiolamine, a new α-glucosidase inhibiting aminocyclitol produced by Streptomyces hygroscopicus. J. Antibiot., 37, 1301-1307.
67. Kameda, Y., Asano, N., Yamaguchi, T., and Matsui, K. (1987) Validoxylamines as trehalase inhibitors. J. Antibiot., 40, 563-565.
68. Karpas, A., Fleet, G.W.J., Dwek, R.A., Petursson, S., Namgoong, S.K., Ramsden, N.G., Jacob, G.S., and Rademacher, T.W. (1988) Amino-sugar derivatives as potential anti-human immunodeficiency virus agents. Proc. Natl Acad. Sci. USA, 85, 9229-9233.
69. 13C NMR spectra and biological activities. Tetrahedron: Asymmetry, 14, 325-331.
70. Khan, K.N., Snook, S.S., Semler, D.E., Baron, D.A., and Alden, C.L. (1996) Pathology of perbutylated-N-butyl-1-deoxynojirimycin (an alpha-glucosidase-1 inhibitor) in Sprague-Dawley rats. Toxicol. Pathol., 24, 531-538.
71. Kim, C.U., Lew, W., Williams, M.A., Liu, H.T., Zhang, L.J., Swaminathan, S., Bischofberger, N., Chen, M.S., Mendel, D.B., Tai, C.Y., and others. (1997) Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc., 119, 681-690.
72. Kyosseva, S.V., Kyossev, Z.N., and Elbein, A.D. (1995) Inhibitors of pig kidney trehalase. Arch. Biochem. Biophys., 316, 821-826.
73. Lee, L., Abe, A., and Shayman, J.A. (1999) Improved inhibitors of glucosylceramide symthase. J. Biol. Chem., 274, 14662-14669.
74. Li, W., Escarp, P.A., Eisenberg, E.J., Cundy, K.C., Sweet, C., Jakeman, K.J., Mersonn, J., Lew, W., Williams, M., Zhang, L., and others. (1998) Identification of GS 4104 as an orally bioavailability prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrob. Agents Chemother., 42, 647-653.
75. Liu, C., Eichelberger, M.C., Compans, R.W., and Air, G.M. (1995) Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J. Virol., 69, 1099-1106.
76. 1-antitrypsin accumulation in the liver. Nature, 357, 605-607.
77. Martin, J.L., Veluraja, K., Ross, K., Johnson, L.N., Fleet, G.W.J., Ramsden, N.G., Bruce, I., Orchard, M.G., Oikonomakos, N.G., Papageorgiou, A.C., and others. (1991) Glucose analogue inhibitors of glycogen phosphorylase: design of potential drugs for diabetes. Biochemistry, 30, 10101-10116.
78. Martin, O.R., Xie, F., and Liu, L. (1995) Synthesis of "α-homogalactostatin" and its 1,N-anhydro derivative. Tetrahedron Lett., 36, 4027-4030.
79. Martin, O.R., Compain, P., Kizu, H., and Asano, N. (1999) Revised structure of α-homonojirimycin isomer from Aglaonema treubii: first example of a naturally occurring α-homoallonojirimycin. Bioorg. Med. Chem. Lett., 9, 3171-3174.
80. Mehta, A., Zitzmann, N., Rudd, P.M., Block, T.M., and Dwek, R.A. (1998) α-Glucosidase inhibitors as potential broad anti-viral agents. FEBS Lett., 430, 17-22.
81. Meindl, P. and Tuppy, H. (1969) 2-Deoxy-2,3-dehydrosialic acids. II. Competitive inhibition of Vibrio cholerae neuraminidase by 2-deoxy-2, 3-dehydro-N-acetylneuraminic acids. Hoppe Seylers Z Physiol. Chem., 350, 1088-1092.
82. Meindl, P., Bodo, G., Palese, P., Schulman, J., and Tuppy, H. (1974) Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virology, 58, 457-463.
83. Misato, T., Ko, K., and Yamaguchi, I. (1977) Use of antibiotics in agriculture. Adv. Appl. Microbiol., 21, 53-88.
84. Murao, S. and Miyata, S. (1980) Isolation and characterization of a new trehalase inhibitor, S-GI. Agric. Biol. Chem., 44, 219-221.
85. Nash, R.J., Bell, E.A., and Williams, J.M. (1985) 2-Hydroxymethyl-3, 4-dihydroxypyrrolidine in fruits of Angylocalyx boutiqueanus. Phytochemistry, 24, 1620-1622.
86. Neufeld, E.F. (1991) Lysosome storage diseases. Ann. Rev. Biochem., 60, 257-280.
87. Nioh, T. and Mizushima, S. (1974) Effect of validamycin on the growth and morphology of Pellicularia sasakii. J. Appl. Microbiol., 20, 373-383.
88. Niwa, T., Inoue, S., Tsuruoka, T., Koaze, Y., and Niida, T. (1970) "Nojirimycin" as a potent inhibitor of glucosidase. Agric. Biol. Chem., 34, 966-968.
89. 1-antitrypsin as an inhibitor of neutrophil elastase. J. Clin. Invest., 89, 1366-1374.
90. Omura, S., Arai, N., Yamaguchi, Y., Masuma, R., Iwai, Y., Namikoshi, M., Turberg, A., Kölbl, H., and Shiomi, K. (2000) Argifin, a new chitinase inhibitor, produced by Gliocladium sp. FTD-0668. J. Antibiot., 53, 603-608.
91. Overkleeft, H.S., Renkema, G.H., Neele, J., Vianello, P., Hung, I.O., Strijland, A., van der Burg, A.M., Koomen, G.-J., Pandit, U.K., and Aerts, J.M.F.G. (1998) Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase. J. Biol. Chem., 41, 26522-26527.
92. Palese, P. and Schulman, J.L. (1977) Inhibitors of viral neuraminidase as potential antiviral drugs. In Oxford, J.S. (Ed.), Chemoprophylaxis and virus infections of the upper respiratory tract, vol. 1. CRC Press, Cleveland, pp. 189-205.
93. Palese, P., Schulman, J.L., Bodo, G., and Meindl, P. (1974) Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetyl neuraminic acid (FANA). Virology, 59, 490-498.
94. Papanikolau, Y., Prag, G., Tavlas, G., Vorgias, C.E., Oppenheim, A.B., and Petratos, K. (2001) High resolution structural analyses of mutant chitinase A complexes with substrates provide new insight into the mechanism of catalysis. Biochemistry, 40, 11338-11343.
95. Pinto, L.H., Holsinger, L.J., and Lamb, R.A. (1992) Influenza virus M2 protein has ion channel activity. Cell, 69, 517-528.
96. Platt, F.M., Neises, G.R., Dwek, R.A., and Butters, T.D. (1994a) N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J. Biol. Chem., 269, 8362-8365.
97. Platt, F.M., Neises, G.R., Karlsson, G.B., Dwek, R.A., and Butters, T.D. (1994b) N-Butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosacchalide processing. J. Biol. Chem., 269, 27108-27114.
98. Puls, W., Keup, U., Krause, H.P., Thomas, G., and Hoffmeister, F. (1977) Glucosidase inhibition. A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia. Naturwissenshaften, 64, 536-537.
99. Remeo, G., Urso, M., Piszcane, A., Blum, E., de Falco, A., and Ruffilli, A. (1975) Residual activity of α-galactosidase A in Fabry's disease. Biochem. Genet., 13, 615-628.
100. Robson, G.D., Kuhn, P.J., and Trinci, A.P.J. (1988) Effects of validamycin A on the morphology, growth and sporulation of Rhizoctonia cerealis, Fusarium culmorum and other fungi. J. Gen. Microbiol., 134, 3187-3194.
101. Sakuda, S., Isogai, A., Matsumoto, S., and Suzuki, A. (1987) Search for microbial insect growth regulators. II. Allosamidin, a novel insect chitinase inhibitor. J. Antibiot., 40, 296-300.
102. Salleh, H.M. and Honek, J.F. (1990) Time-dependent inhibition of porcine kidney trehalase by aminosugars. FEBS Lett., 262, 359-362.
103. Sawkar, A.R., Cheng, W.-C., Beutler, E., Wong, C.-H., Balch, W.E., and Kelly, J.W. (2002) Chemical chaperones increase the cellular activity of N370S β-glucosidase: a therapeutic strategy for Gaucher disease. Proc. Natl Acad. Sci. USA, 99, 15428-15433.
104. Schmidt, D.D., Frommer, W., Müller, L., Junge, B., Wingender, W., and Truscheit, E. (1977) α-Glucosidase inhibitors, new complex oligosaccharides of microbial origin. Naturwissenshaften, 64, 535-536.
105. Schmidt, D.D., Frommer, W., Müller, L., and Truscheit, E. (1979) Glucosidase inhibitors from bacilli. Naturwissenshaften, 66, 584-585.
106. Sferra, T.J. and Collins, F.S. (1993) The molecular biology of cystic fibrosis. Annu. Rev. Med., 44, 133-144.
107. Singh, S., Jedrzejas, M.J., Air, G.M., Luo, M., Laver, W.G., and Brouillette, W.J. (1995) Structure based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. J. Med. Chem., 38, 3217-3225.
108. Sudbeck, E.A., Jedrzejas, M.J., Singh, S., Brouillette, W.J., Air, G.M., Laver, W.G., Babu, Y.S., Bantia, S., Chand, P., Chu, N., and others. (1997) Guanidinobenzoic acid inhibitors of influenza virus neuraminidase. J. Mol. Biol., 267, 584-594.
109. Sunkara, P.S., Taylor, D.L., Kang, M.S., Bowlin, T.L., Liu, P.S., and Tyms, A.S. (1989) Anti-HIV activity of castanospermine analogues. Lancet, 1206.
110. Taylor, D.L., Sunkara, P.S., Liu, P.S., Kang, M.S., Bowlin, T.L., and Tyms, A.S. (1991) 6-O-butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs. AIDS, 5, 693-698.
111. Taylor, N.R. and von Itzstein, M. (1994) Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis. J. Med. Chem., 37, 616-624.
112. Teckman, J., Qu, D., and Perlmutter, D.H. (1996) Molecular pathogenesis of α-antitrypsin deficiency. Hepatology, 24, 1504-1516.
113. Thevelein, J.M. (1984) Regulation of trehalose mobilization in fungi. Microbiol. Rev., 48, 42-59.
114. Tifft, C.J. and Proia, R.L. (2000) Stemming the tide: glycosphingolipid synthesis inhibitors as therapy for storage diseases. Glycobiology, 10, 1249-1258.
115. Tominaga, L., Ogawa, Y., Taniguchi, M., Ohno, K., Matsuda, J., Oshima, A., Suzuki, Y., and Nanba, E. (2001) Galactonojirimycin derivatives restore mutant human β-galactosidase activities expressed in fibroblasts from enzyme-deficient knockout mouse. Brain Dev., 23, 284-287.
116. Trinci, A.P.J. (1985) Effect of validamycin A and L-sorbose on the growth and morphology of Rhizoctonia cerealis and Rhizoctonia solani. Exp. Mycol., 9, 20-27.
117. van Aalten, D.M.F., Synstad, B., Brurberg, M.B., Hough, E., Riise, B.W., Eijsink, V.G.H., and Wierenga, R.K. (2000) Structure of a two-domain chitotriosidase from Serratia marcescens at 1.9-Å resolution. Proc. Natl Acad. Sci. USA, 97, 5842-5847.
118. van Aalten, D.M.F., Komander, D., Synstad, B., Gåseidnes, S., Peter, M.G., and Eijsink, V.G.H. (2001) Structural insights into the catalytic mechanism of a family 18 exo-chitinase. Proc. Natl Acad. Sci. USA, 98, 8979-8984.
119. Varghese, J.N., Laver, W.G., and Colman, P.M. (1983) Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution. Nature, 303, 35-40.
120. Vértesy, L., Fehlhaber, H.-W., and Schulz, A. (1994) The trehalase inhibitor salbostatin, a novel metabolite from Streptomyces albus, ATCC 21838. Angew. Chem. Int. Ed. Engl., 33, 1844-1847.
121. von Itzstein, M., Wu, W.-Y., Kok, G.B., Pegg, M.S., Dyason, J.C., Jin, B., Van Phan, T., Smythe, M.L., White, H.F., Oliver, S.W., and others. (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature, 363, 418-423.
122. von Itzstein, M., Wu, W.-Y., and Jin, B. (1994) The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor. Carbohydr. Res., 259, 301-305.
123. von Itzstein, M., Dyason, J.C., Oliver, S.W., White, H.F., Wu, W.-Y., Kok, G.B., and Pegg, M.S. (1996) A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs. J. Med. Chem., 39, 388-391.
124. Welch, W.J. and Brown, C.R. (1996) Influence of molecular and chemical chaperones on protein folding. Cell Stress Chap., 1, 109-115.
125. Welsh, M.J. and Smith, A.E. (1993) Molecular mechanism of CFTR chloride channel dysfunction in cystic fibrosis. Cell, 73, 1251-1254.
126. Williams, M., Bischofberger, N., Swaminathan, S., and Kim, C.U. (1995) Synthesis and influenza inhibitory activity of aromatic analogues of sialic acid. Bioorg. Med. Chem. Lett., 5, 2251-2254.
127. Winn, W.C. and Westenfeld, F.W. (1995) Images in clinical medicine. Influenza A virus. N. Engl. J. Med., 333, 912.
128. Yagi, M., Kouno, T., Aoyagi, Y., and Murai, H. (1976) The structure of molanoline, a piperidine alkaloid from Morus species. Nippon Nogei Kagaku Kaishi, 50, 571-572.
129. Yang, C., Zhu, Y., Magee, D.M., and Cox, R.A. (1996) Molecular cloning and characterization of the Coccidioides immitis complement fixation/chitinase antigen. Infect. Immun., 64, 1992-1997.
130. Yoshikawa, M., Murakami, T., Shimada, H., Matsuda, H., Yamahara, J., Tanabe, G., and Muraoka, O. (1997) Salacinol, potent antidiabetic principle with unique thiosugar sulfonium sulfate structure from the ayurvedic traditional medicine Salacia reticulata in Sri Lanka and India. Tetrahedron Lett., 38, 8367-8370.
131. Yoshikawa, M., Murakami, T., Yashiro, K., and Matsuda, H. (1998) Kotalanol, a potent α-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic Ayurvedic medicine Salacia reticulata. Chem. Pharm. Bull., 46, 1339-1340.
132. 1-antitrypsin causes a protein folding defect. Nat. Struct. Biol., 2, 363-367.
133. Zitzmann, N., Mehta, A.S., Carrouée, S., Butters, T.D., Platt, F.M., McCauley, J., Blumberg, B.S., Dwek, R.A., and Block, T.M. (1999) Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc. Natl Acad. Sci. USA, 96, 11878-11882.